Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A01N-043/04
A01N-043/02
C12N-015/87
A61K-031/70
A61K-039/00
출원번호
US-0610601
(2003-07-02)
등록번호
US-7358234
(2008-04-15)
발명자
/ 주소
Johnston,Stephen A.
Sanford,John C.
출원인 / 주소
Duke University
E.I. du Pont de Nemours & Company
대리인 / 주소
Crane,Sharon E.
인용정보
피인용 횟수 :
0인용 특허 :
19
초록▼
The present invention relates to a process for inducing a protective immune response in a mammal against a virus, in which a construct including a promoter and a DNA sequence encoding a protein or peptide producing an immune response against the virus is introduced into muscle or skin of the mammal
The present invention relates to a process for inducing a protective immune response in a mammal against a virus, in which a construct including a promoter and a DNA sequence encoding a protein or peptide producing an immune response against the virus is introduced into muscle or skin of the mammal via a microprojectile. Sufficient amounts of the construct are administered so as to produce a protective immune response in the mammal.
대표청구항▼
That which is claimed is: 1. A process for inducing a protective immune response against a virus in a mammal, comprising; introducing into muscle or skin of said mammal a construct comprising a DNA sequence encoding a protein or peptide producing an immune response against said virus linked to a pr
That which is claimed is: 1. A process for inducing a protective immune response against a virus in a mammal, comprising; introducing into muscle or skin of said mammal a construct comprising a DNA sequence encoding a protein or peptide producing an immune response against said virus linked to a promoter sequence which can control the expression of said DNA sequence in said mammal, in an amount such that sufficient expression results, to produce said protective immune response, wherein said construct is introduced into the mammal via a microprojectile. 2. The process of claim 1, wherein said DNA sequence is introduced into muscle. 3. The process of claim 1, wherein said DNA sequence is introduced into skin. 4. The process of claim 1, wherein said mammal is a human. 5. The process of claim 3, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 6. The process of claim 1, wherein said protein or peptide producing an immune response is a viral protein. 7. The process of claim 1, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine. 8. A process for providing a mammal with a protein or peptide producing a protective immune response against a virus, and thereby generating a desired protective immune response in said mammal due to the action of the immune system of said mammal on said protein or peptide, comprising: introducing into muscle or skin of said mammal a construct comprising a DNA sequence encoding said protein or peptide linked to a promoter sequence which can control the expression of said DNA sequence in said mammal, in an amount that sufficient expression results, to generate said protective immune response, wherein said construct is introduced into the mammal via a microprojectile. 9. The process of claim 8, wherein said DNA sequence is introduced into muscle. 10. The process of claim 8, wherein said DNA sequence is introduced into skin. 11. The process of claim 8, wherein said mammal is a human. 12. The process of claim 10, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 13. The process of claim 8, wherein said protein or peptide producing an immune response is a viral protein. 14. The process of claim 8, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine. 15. A process for inducing a protective immune response against a virus in a mammal, comprising; introducing into the epidermis of said mammal a construct comprising a DNA sequence encoding a protein or peptide producing an immune response against said virus linked to a promoter sequence which can control the expression of said DNA sequence in said mammal, in an amount such that sufficient expression results, to produce said protective immune response, wherein said construct is introduced into the mammal via a microprojectile. 16. The process of claim 15, wherein said DNA sequence is introduced into muscle. 17. The process of claim 15, wherein said DNA sequence is introduced into skin. 18. The process of claim 15, wherein said mammal is a human. 19. The process of claim 17, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 20. The process of claim 15, wherein said protein or peptide producing an immune response is a viral protein. 21. The process of claim 15, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine. 22. A method of generating an immune response against a virus in a mammal, comprising: administering in vivo into a tissue of a mammal in need of said immune response a composition comprising a DNA plasmid which directs synthesis of an immunogenic peptide or polypeptide in mammalian cells through association with a promoter; wherein said DNA plasmid incorporates into the cells of said mammal; and wherein sufficient expression of said immunogenic peptide or polypeptide occurs to generate said immune response against said virus in said mammal, wherein said DNA plasmid is administered via a microprojectile. 23. The process of claim 22, wherein said DNA sequence is introduced into muscle. 24. The process of claim 22, wherein said DNA sequence is introduced into skin. 25. The process of claim 22, wherein said mammal is a human. 26. The process of claim 24, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 27. The process of claim 22, wherein said protein or peptide producing an immune response is a viral protein. 28. The process of claim 22, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine. 29. A method of generating an immune response against a virus in a mammal, comprising: administering in vivo into a tissue of a mammal in need of said immune response a composition consisting essentially of a DNA plasmid operably encoding an immunogenic peptide or polypeptide through association with a promoter; wherein said plasmid incorporates into the cells of said mammal; and wherein sufficient expression of said immunogenic peptide or polypeptide occurs to generate said immune response against said virus in said mammal, wherein said DNA plasmid is administered via a microprojectile. 30. The process of claim 29, wherein said DNA sequence is introduced into muscle. 31. The process of claim 29, wherein said DNA sequence is introduced into skin. 32. The process of claim 29, wherein said mammal is a human. 33. The process of claim 31, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 34. The process of claim 29, wherein said protein or peptide producing an immune response is a viral protein. 35. The process of claim 29, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine. 36. A method of generating an immune response against a virus in a mammal, comprising: administering in vivo into a tissue of a mammal in need of said immune response a composition consisting of a DNA plasmid operably encoding an immunogenic peptide or polypeptide through association with a promoter; wherein said plasmid incorporates into the cells of said mammal; and wherein sufficient expression of said immunogenic peptide or polypeptide occurs to generate said immune response against said virus in said mammal, wherein said DNA plasmid is administered via a microprojectile. 37. The process of claim 36, wherein said DNA sequence is introduced into muscle. 38. The process of claim 36, wherein said DNA sequence is introduced into skin. 39. The process of claim 36, wherein said mammal is a human. 40. The process of claim 38, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 41. The process of claim 36, wherein said protein or peptide producing an immune response is a viral protein. 42. The process of claim 36, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine. 43. A method of generating an immune response against a virus in a mammal, comprising: administering in vivo into muscle tissue of a mammal in need of said immune response a composition comprising a polynucleotide which directs synthesis of an immunogenic peptide or polypeptide in mammalian cells; wherein said polynucleotide is selected from the group consisting of a messenger RNA and a DNA plasmid operably encoding said immunogenic peptide or polypeptide through association with a promoter; wherein said polynucleotide incorporates into the cells of said mammal; and wherein sufficient expression of said immunogenic peptide or polypeptide occurs to generate said immune response against said virus in said mammal, wherein said polynucleotide is administered via a microprojectile. 44. The process of claim 43, wherein said DNA sequence is introduced into muscle. 45. The process of claim 43, wherein said DNA sequence is introduced into skin. 46. The process of claim 43, wherein said mammal is a human. 47. The process of claim 45, wherein said DNA sequence is introduced into a layer of skin selected from the following group: epidermis, dermis, or hypodermis. 48. The process of claim 43, wherein said protein or peptide producing an immune response is a viral protein. 49. The process of claim 43, wherein said protein or peptide producing an immune response is produced from a nucleotide sequence encoding a protein or peptide immunogen coding for a subunit vaccine.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (19)
Harnden Michael Raymond (Horsham EN), Biologically active material.
Ladner Robert C. (3827 Green Valley Iamsville MD 21754), Computer based system and method for determining and displaying possible chemical structures for converting double- or m.
Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Induction of a protective immune response in a mammal by injecting a DNA sequence.
Sanford John C. (Geneva) DeVit Michael J. (Geneva NY) Bruner Ronald F. (Sewell NJ) Johnston Stephen A. (Durham NC), Method and apparatus for introducing biological substances into living cells.
Sanford John C. (Geneva NY) Wolf Edward D. (Ithaca NY) Allen Nelson K. (Newfield NY), Method for transporting substances into living cells and tissues.
Sanford John C. (Geneva NY) Wolf Edward D. (Ithaca NY) Allen Nelson K. (Newfield NY), Method for transporting substances into living cells and tissues and apparatus therefor.
Szoka ; Jr. Francis C. (76 Summit St. Waltham MA 02154) Papahadjopoulos Demetrios P. (3170 Condit St. Lafayette CA 94549), Method of inserting DNA into living cells.
Evans Ronald M. (La Jolla CA) Palmiter Richard D. (Seattle WA) Brinster Ralph L. (Gladwyne PA), Method of obtaining gene product through the generation of transgenic animals.
Johnston Stephen A. ; Williams R. Sanders ; Sanford John C. ; McElligott Sandra G., Particle-mediated bombardment of DNA sequences into tissue to induce an immune response.
Viza Dimitri (Bourg-la-Reine FRX) Adamopoulos Dimitri (Athens GRX) Phillips John (L\Hay les Romes FRX), Production of specific immune nucleic acids cell dialysates and antibodies.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.